" /> BCR/ABL1 Fusion Gene with ABL1 NM_005157.4:c.951C A Mutation - CISMeF





Preferred Label : BCR/ABL1 Fusion Gene with ABL1 NM_005157.4:c.951C A Mutation;

NCIt synonyms : BCR/ABL1 Fusion Gene with ABL1 NM_005157.5:c.951C A; BCR/ABL1 Fusion Gene with NM_005157.4:c.951C A; BCR/ABL Fusion Gene with NM_005157.5:c.951C A; BCR/ABL Fusion Gene with NM_005157.4:c.951C A; BCR::ABL1 Fusion Gene with ABL1 NM_005157.4:c.951C A Mutation;

NCIt definition : A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of a mutated form of the ABL1 gene. In this fusion gene there is a point mutation where cytosine has been substituted with adenine at nucleotide position 951 of the ABL1 gene. This mutation is associated with imatinib- and dasatinib-resistant leukemias.;

NCIt note : The position of the point mutation is denoted by its location in the ABL1 cDNA sequence (NCBI Reference Sequence: NM_005157.4) and not its location in the fusion gene cDNA.;

NCI Metathesaurus CUI : CL513811;

SNP ID : rs121913451;

Détails


Vous pouvez consulter :


Nous contacter.
30/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.